Zespół krótkiego jelita
Leczenie

Zespół krótkiego jelita (SBS) to poważne zaburzenie wchłaniania wynikające z resekcji ponad 2/3 jelita cienkiego lub jego dysfunkcji, wymagające kompleksowego leczenia wielodyscyplinarnego. Terapia obejmuje fazy ostre, adaptacyjne i utrzymania, z kluczowym zastosowaniem żywienia pozajelitowego (TPN) oraz dojelitowego (EN), dostosowanego do długości i funkcji pozostałego jelita. W początkowej fazie TPN dostarcza pełne zapotrzebowanie na białka, węglowodany, tłuszcze, witaminy i minerały, często przez cewnik centralny, a w fazie adaptacji stopniowo zwiększa się udział żywienia dojelitowego i doustnego. Zalecenia dietetyczne obejmują małe, częste posiłki, dietę bogatą w białko, unikanie napojów hipertonicznych oraz suplementację witamin (B12, A, D, E, K) i minerałów (wapń, magnez, potas, cynk, żelazo, selen). Kluczowe jest także utrzymanie odpowiedniej diurezy (>1500 ml/dobę) i nawodnienia, stosując doustne roztwory nawadniające (ORS) oraz monitorowanie bilansu płynów i elektrolitów.

Zespół krótkiego jelita – charakterystyka leczenia

Zespół krótkiego jelita (ang. Short Bowel Syndrome, SBS) to rzadkie zaburzenie wchłaniania, które pojawia się w wyniku rozległej resekcji jelita cienkiego (zwykle ponad dwie trzecie długości jelita cienkiego) lub braku funkcjonalności jelita cienkiego. Leczenie zespołu krótkiego jelita wymaga kompleksowego, wielodyscyplinarnego podejścia z zastosowaniem wsparcia żywieniowego, farmakoterapii oraz, w niektórych przypadkach, interwencji chirurgicznych.123

Cele leczenia zespołu krótkiego jelita

Główne cele leczenia zespołu krótkiego jelita obejmują:12

  • Zapewnienie odpowiedniego odżywienia i nawodnienia organizmu
  • Maksymalizację wchłaniania jelitowego
  • Zmniejszenie lub eliminację zapotrzebowania na żywienie pozajelitowe
  • Promowanie adaptacji jelitowej
  • Minimalizację powikłań związanych z chorobą i leczeniem
  • Poprawę jakości życia pacjentów

Fazy leczenia zespołu krótkiego jelita

Leczenie zespołu krótkiego jelita można podzielić na kilka faz, w zależności od stadium adaptacji jelitowej:123

Faza ostra (0-3 miesiące)

W fazie ostrej, większość pacjentów doświadcza niewydolności jelit, co oznacza, że jelito cienkie nie jest w stanie wchłaniać wystarczającej ilości składników odżywczych do utrzymania zdrowia lub wspomagania wzrostu u dzieci. W tym okresie pacjenci wymagają:13

Faza adaptacji (3 miesiące – 2 lata)

W miarę adaptacji jelit i zwiększania ich zdolności absorpcyjnych, leczenie koncentruje się na:134

  • Stopniowym zwiększaniu żywienia dojelitowego
  • Redukcji żywienia pozajelitowego
  • Wprowadzaniu diety doustnej
  • Stymulowaniu adaptacji jelitowej

Faza utrzymania (powyżej 2 lat)

W fazie utrzymania jelita osiągnęły maksymalną możliwą adaptację. W zależności od skuteczności adaptacji jelitowej:134

  • Niektórzy pacjenci mogą być całkowicie uniezależnieni od żywienia pozajelitowego
  • Inni będą wymagać częściowego lub całkowitego żywienia pozajelitowego przez całe życie
  • Pacjenci z przewlekłą niewydolnością jelit mogą kwalifikować się do przeszczepu jelita

Wsparcie żywieniowe w zespole krótkiego jelita

Wsparcie żywieniowe stanowi podstawę leczenia zespołu krótkiego jelita. Dobór odpowiedniej strategii żywieniowej zależy od zaawansowania choroby, zachowanej długości i funkcji jelita oraz indywidualnych potrzeb pacjenta.12

Żywienie pozajelitowe (PN)

Całkowite żywienie pozajelitowe (TPN) jest kluczowym elementem leczenia pacjentów z zespołem krótkiego jelita, szczególnie w początkowej fazie po resekcji jelita. TPN dostarcza wszystkie niezbędne składniki odżywcze, w tym białka, węglowodany, tłuszcze, witaminy i minerały, bezpośrednio do krwiobiegu przez cewnik wprowadzony do dużej żyły (najczęściej centralnej).123

Żywienie pozajelitowe może być prowadzone:12

  • W warunkach szpitalnych (szczególnie w fazie ostrej)
  • W warunkach domowych (HPN) – dla pacjentów wymagających długotrwałego żywienia pozajelitowego

Pacjenci z krótszym odcinkiem jelita cienkiego (poniżej 60-100 cm) oraz ci, którzy utracili jelito krętnicze i zastawkę krętniczo-kątniczą, zwykle wymagają długotrwałego, a niekiedy dożywotniego żywienia pozajelitowego.12

Żywienie dojelitowe (EN)

Żywienie dojelitowe polega na dostarczaniu płynnych pokarmów bezpośrednio do żołądka lub jelita cienkiego przez zgłębnik lub gastrostomię (PEG) lub jejunostomię. Żywienie dojelitowe jest ważne ponieważ:123

  • Stymuluje adaptację jelitową
  • Wspomaga proces trawienia
  • Dostarcza składniki odżywcze w wolniejszym tempie niż przy spożywaniu doustnym
  • Może pomóc w utrzymaniu lub poprawie zdolności absorpcyjnych pozostałego jelita

Żywienie dojelitowe jest często stosowane równolegle z żywieniem pozajelitowym, szczególnie w początkowych fazach adaptacji jelitowej.12

Dieta doustna i modyfikacje żywieniowe

Wraz z poprawą funkcji jelita, pacjenci stopniowo przechodzą na doustne spożywanie pokarmów. Zalecenia dietetyczne dla pacjentów z zespołem krótkiego jelita obejmują:123

  • Spożywanie małych, częstych posiłków (co 2-3 godziny) zamiast kilku dużych
  • Dokładne żucie pokarmów, aby ułatwić rozkład
  • Dietę bogatą w białko
  • Lepszą tolerancję złożonych węglowodanów niż prostych
  • Unikanie napojów hipertonicznych (słodzone napoje gazowane, soki)
  • W przypadku nietolerancji laktozy, stosowanie diety niskołaktozowej
  • Ograniczenie spożycia pokarmów bogatych w szczawiany (np. szpinak)

Zalecana jest współpraca z dietetykiem specjalizującym się w leczeniu zespołu krótkiego jelita, który pomoże opracować indywidualny plan żywieniowy.12

Nawodnienie i równowaga elektrolitowa

Odpowiednie nawodnienie jest kluczowym elementem leczenia zespołu krótkiego jelita. Pacjenci z SBS są narażeni na odwodnienie i zaburzenia elektrolitowe, szczególnie przy dużych stratach płynów przez biegunkę lub stomię.12

Strategie utrzymania prawidłowego nawodnienia obejmują:12

  • Doustne roztwory nawadniające (ORS) – lekko słone i lekko słodkie płyny, które pomagają w absorpcji wody i elektrolitów
  • Dożylne podawanie płynów i elektrolitów w przypadku ciężkiego odwodnienia
  • Monitorowanie bilansu płynów, masy ciała i parametrów nerkowych
  • Utrzymanie odpowiedniej diurezy (>1500 ml/dobę) w celu zapobiegania kamicy nerkowej

Farmakoterapia w zespole krótkiego jelita

Leczenie farmakologiczne stanowi ważny element terapii zespołu krótkiego jelita. Leki stosowane w SBS mają za zadanie łagodzić objawy, poprawiać wchłanianie składników odżywczych oraz stymulować adaptację jelitową.12

Leki przeciwbiegunkowe i spowalniające perystaltykę

Biegunka jest jednym z głównych objawów zespołu krótkiego jelita. Leki stosowane w jej leczeniu:123

  • Loperamid – należy przyjmować co najmniej 30 minut przed posiłkiem, aby spowolnić pasaż jelitowy i zwiększyć czas kontaktu pokarmu ze śluzówką jelita
  • Kodeina – alternatywny lek przeciwbiegunkowy
  • Difenoksylat z atropiną – lek złożony o działaniu przeciwbiegunkowym
  • Oktreotyd – analog somatostatyny, może zmniejszyć wydzielanie jelitowe i spowolnić perystaltykę, redukując objętość stolca nawet o 50% (stosowany głównie u pacjentów z końcową jejunostomią)

Leki hamujące wydzielanie kwasu żołądkowego

Nadmierne wydzielanie kwasu żołądkowego może pogorszyć objawy SBS i zmniejszyć skuteczność enzymów trzustkowych. Leki stosowane w celu zmniejszenia wydzielania kwasu:123

  • Inhibitory pompy protonowej (np. omeprazol)
  • Antagoniści receptora H2 (np. ranitydyna)

Leki wiążące kwasy żółciowe

U pacjentów po resekcji jelita krętego często występuje biegunka spowodowana malabsorpcją kwasów żółciowych. W takich przypadkach stosuje się:12

  • Cholestyramina – lek wiążący kwasy żółciowe, podawany z posiłkami w dawce 2-4 g

Antybiotyki

Przerost bakteryjny jelita cienkiego (SIBO) jest częstym powikłaniem u pacjentów z SBS. Antybiotyki stosowane w jego leczeniu:12

  • Rifaksymina – antybiotyk niewchłanialny z przewodu pokarmowego, skuteczny w leczeniu SIBO
  • Cyprofloksacyna
  • Metronidazol

Hormony troficzne i czynniki wzrostu

Innowacyjne terapie hormonalne mają na celu stymulację adaptacji jelitowej i poprawę funkcji wchłaniania:123

  • Teduglutyd (Gattex) – analog ludzkiego peptydu glukagonopodobnego-2 (GLP-2), zatwierdzony przez FDA do leczenia dorosłych i dzieci (od 1. roku życia) z zespołem krótkiego jelita zależnych od żywienia pozajelitowego. Teduglutyd działa poprzez regenerację komórek w wyściółce jelitowej, poprawiając wchłanianie płynów i składników odżywczych. W badaniach klinicznych teduglutyd pozwolił na redukcję objętości żywienia pozajelitowego o 20-100% u znacznej liczby pacjentów.
  • Somatropina (Zorbtive) – rekombinowany ludzki hormon wzrostu, który może stymulować adaptację jelitową i poprawiać wchłanianie.
  • Apraglutyd – nowy analog GLP-2, będący obecnie w fazie badań klinicznych do leczenia SBS z niewydolnością jelit.

Zarówno teduglutyd, jak i apraglutyd podawane są w formie iniekcji podskórnych.123

Suplementacja witamin i minerałów

Pacjenci z zespołem krótkiego jelita często wymagają suplementacji witamin i minerałów z powodu ich niedostatecznego wchłaniania:123

  • Witamina B12 – podawana domięśniowo co miesiąc u pacjentów z udokumentowanym niedoborem, szczególnie po resekcji jelita krętego
  • Witaminy rozpuszczalne w tłuszczach (A, D, E, K)
  • Minerały: wapń, magnez, potas, chlorki, cynk, żelazo, selen
  • Preparaty wielowitaminowe

Leczenie chirurgiczne zespołu krótkiego jelita

Interwencje chirurgiczne odgrywają ważną rolę w leczeniu zespołu krótkiego jelita, szczególnie u pacjentów, u których inne metody terapeutyczne nie przynoszą zadowalających efektów.12

Zabiegi chirurgiczne nietransplantacyjne

Celem zabiegów nietransplantacyjnych jest poprawa funkcji pozostałego jelita, zwiększenie jego długości lub spowolnienie pasażu jelitowego:123

  • Procedura Bianchi (LILT – Longitudinal Intestinal Lengthening and Tailoring) – polega na podłużnym rozcięciu poszerzonego odcinka jelita i ponownym zszyciu, co podwaja długość jelita przy zachowaniu tej samej powierzchni wchłaniania
  • Enteroplastyka poprzeczna seryjną (STEP) – zabieg, w którym jelito jest przecinane i zszywane w układzie zygzakowatym, co wydłuża jelito i spowalnia pasaż treści pokarmowej
  • Zwężenie niefunkcjonalnych, poszerzonych odcinków jelita
  • Tworzenie zastawek jelitowych lub odwrócenie segmentów jelita dla pacjentów z szybkim czasem pasażu jelitowego
  • Interponowanie segmentów okrężnicy do jelita cienkiego
  • Plastyka zwężeń (strictureplasty) – poszerzanie zwężonych odcinków jelita

Przeszczep jelita

Transplantacja jelita jest rozważana jako opcja leczenia dla pacjentów z przewlekłą niewydolnością jelit, którzy wymagają długotrwałego żywienia pozajelitowego i rozwijają zagrażające życiu powikłania.123

Wskazania do transplantacji jelita obejmują:123

  • Brak dostępu naczyniowego do żywienia pozajelitowego
  • Nawracające epizody posocznicy związanej z cewnikiem centralnym
  • Postępującą chorobę wątroby związaną z żywieniem pozajelitowym
  • Nieodwracalną niewydolność jelit

Rodzaje przeszczepów jelitowych:12

  • Izolowany przeszczep jelita cienkiego – dla pacjentów z zachowaną funkcją wątroby
  • Przeszczep wielonarządowy – przeszczep jelita w połączeniu z przeszczepem wątroby i/lub innych narządów jamy brzusznej u pacjentów z niewydolnością wątroby związaną z SBS

Chociaż transplantacja jelita może być ratująca życie, wiąże się z ryzykiem powikłań, w tym z odrzuceniem przeszczepu i zwiększoną podatnością na infekcje z powodu konieczności stosowania immunosupresji.12

Nowe kierunki w leczeniu zespołu krótkiego jelita

Badania nad nowymi metodami leczenia zespołu krótkiego jelita koncentrują się na kilku obiecujących obszarach:12

Inżynieria tkankowa i medycyna regeneracyjna

Inżynieria tkankowa oferuje potencjalne rozwiązania dla pacjentów z SBS:123

  • Sztuczne jelito (TESI) – wyhodowane z własnych komórek macierzystych pacjenta
  • Bioimplantaty jelitowe – hodowla tkanki jelitowej na biozgodnych rusztowaniach
  • Terapie komórkami macierzystymi – do regeneracji uszkodzonej tkanki jelitowej lub układu nerwowego jelita

Badania w ramach projektu INTENS wykazały możliwość tworzenia spersonalizowanych przeszczepów jelita czczego dla dzieci z niewydolnością jelit, co w przyszłości może przywrócić im autonomię żywieniową.123

Sprężyny rozprężające jelito

Innowacyjne podejście do leczenia zespołu krótkiego jelita u dzieci zostało opracowane przez dr. Jamesa Dunna ze Stanford University. Jego metoda wykorzystuje endoluminalne sprężyny indukujące enterogenezę dystrakcyjną (distraction enterogenesis-inducing endoluminal coils), które mogą rozciągać i wydłużać jelito.12

Wielodyscyplinarne podejście w leczeniu zespołu krótkiego jelita

Ze względu na złożoność zespołu krótkiego jelita, optymalne leczenie wymaga współpracy specjalistów z różnych dziedzin:123

  • Gastroenterolodzy – koordynacja leczenia i optymalizacja farmakoterapii
  • Chirurdzy – wykonanie zabiegów chirurgicznych i przeszczepów
  • Specjaliści ds. żywienia/dietetycy – opracowanie planów żywieniowych
  • Pielęgniarki specjalistyczne – opieka nad dostępami naczyniowymi, stomią
  • Farmaceuci – optymalizacja farmakoterapii
  • Pracownicy socjalni – wsparcie społeczne i finansowe
  • Psycholodzy – wsparcie psychologiczne
  • Fizjoterapeuci, terapeuci zajęciowi i logopedzi – szczególnie ważni w leczeniu dzieci

Zapobieganie powikłaniom w zespole krótkiego jelita

Zespół krótkiego jelita może prowadzić do licznych powikłań, których zapobieganie stanowi ważny element terapii:12

Powikłania związane z żywieniem pozajelitowym

Długotrwałe żywienie pozajelitowe może prowadzić do poważnych powikłań:123

  • Zakażenia związane z cewnikiem centralnym – zapobieganie obejmuje stosowanie protokołów blokady etanolowej lub wodorowęglanu sodu
  • Zakrzepica żylna – związana z obecnością cewnika centralnego
  • Choroby wątroby związane z żywieniem pozajelitowym (PNALD/IFALD) – mogą obejmować stłuszczenie wątroby, cholestazę lub nawet zwłóknienie i marskość
  • Zaburzenia metaboliczne – hiperglikemia, zaburzenia elektrolitowe

Strategie minimalizacji ryzyka obejmują optymalizację składu żywienia pozajelitowego, stosowanie nowych emulsji lipidowych oraz protokoły minimalizacji lipidów.12

Inne powikłania zespołu krótkiego jelita

Poza powikłaniami związanymi z żywieniem pozajelitowym, pacjenci z SBS są narażeni na:12

  • Zaburzenia elektrolitowe – monitorowanie i suplementacja
  • Kamica nerkowa – odpowiednie nawodnienie i kontrola oksalurii
  • Niedobory witamin i minerałów – regularna suplementacja i monitorowanie poziomów
  • Przerost bakteryjny jelita cienkiego – cykliczna antybiotykoterapia

Znaczenie edukacji i wsparcia psychospołecznego

Edukacja pacjenta i jego rodziny oraz wsparcie psychospołeczne są kluczowymi elementami skutecznego leczenia zespołu krótkiego jelita:123

  • Edukacja na temat diety, leków i obsługi sprzętu do żywienia pozajelitowego
  • Wsparcie psychologiczne – pomoc w radzeniu sobie ze stresem, lękiem i depresją związanymi z przewlekłą chorobą
  • Grupy wsparcia dla pacjentów i ich rodzin
  • Telemedycyna – umożliwiająca regularne konsultacje bez konieczności częstych wizyt w szpitalu

Podsumowanie leczenia zespołu krótkiego jelita

Leczenie zespołu krótkiego jelita wymaga kompleksowego, wielodyscyplinarnego podejścia dostosowanego do indywidualnych potrzeb pacjenta. Kluczowym elementem terapii jest wsparcie żywieniowe, farmakoterapia oraz, w wybranych przypadkach, interwencje chirurgiczne.12

W ostatnich latach nastąpił znaczący postęp w leczeniu zespołu krótkiego jelita, szczególnie w zakresie farmakoterapii (teduglutyd, somatropina) oraz technik chirurgicznych. Obiecujące wydają się również badania nad inżynierią tkankową i medycyną regeneracyjną, które w przyszłości mogą zaoferować nowe możliwości terapeutyczne dla pacjentów z SBS.123

Celem ostatecznym leczenia jest osiągnięcie autonomii jelitowej, poprawa jakości życia pacjentów oraz zapobieganie powikłaniom związanym z chorobą i jej leczeniem.12

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 12.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Treatment of Short Bowel Syndrome – NIDDK
    https://www.niddk.nih.gov/health-information/digestive-diseases/short-bowel-syndrome/treatment
    Doctors treat short bowel syndrome with nutrition support, fluids and electrolytes, medicines, and surgery. The goals of treatment are to make sure you get enough nutrients. […] The main treatment for short bowel syndrome is nutrition support. The type and amount of nutrition support you need may depend on what stage your short bowel syndrome is in and how severe the syndrome is. […] In the acute stage, most people have intestinal failure, meaning the small intestine cannot absorb enough nutrients to maintain health or to support growth in children. During this stage, your doctor may recommend parenteral nutrition, in which you receive nutrients through an IV inserted into a vein. […] As your intestines adapt and absorb more nutrients, your doctor or dietitian may recommend more enteral nutrition, more foods and drinks, and less parenteral nutrition, or, if your intestines adapt enough, stopping parenteral nutrition.
  • #1 Treatment of Short Bowel Syndrome – NIDDK
    https://www.niddk.nih.gov/health-information/digestive-diseases/short-bowel-syndrome/treatment
    If your intestines still cannot absorb enough nutrients to keep you healthy, this condition is called chronic intestinal failure. Your doctor may recommend long-term parenteral nutrition or surgery to treat chronic intestinal failure. […] To prevent dehydration, doctors may recommend IV fluids and electrolytes. […] Doctors may recommend or prescribe medicines to help treat short bowel syndrome, including proton pump inhibitors or H2 blockers, which lower the amount of acid the stomach makes. […] In some cases, doctors recommend surgery to help treat short bowel syndrome. Doctors may recommend surgery to place a tube, called a catheter, in a vein to provide parenteral nutrition and IV fluids. […] Some people with short bowel syndrome may need an intestinal transplant. Doctors may recommend an intestinal transplant for people who have chronic intestinal failure, need long-term parenteral nutrition, and develop life-threatening complications.
  • #1 Short bowel syndrome – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/short-bowel-syndrome/diagnosis-treatment/drc-20450377
    Treatment options for short bowel syndrome will depend on what parts of the small intestine are affected, whether the colon is intact and a person’s own preferences. […] Short bowel syndrome treatment may include: […] Nutritional therapy. People with small bowel syndrome will need to follow a special diet and take nutritional supplements. Some people may need to get nutrition through a vein, called parenteral nutrition, or a feeding tube, called enteral nutrition. This is to prevent malnutrition. […] Medicines. In addition to nutritional support, medicines to help manage short bowel syndrome may be recommended. These include medicines to help control stomach acid, reduce diarrhea or improve intestinal absorption after surgery. […] Surgery. Types of surgery to treat short bowel syndrome include procedures to slow the passage of nutrients through the intestine or a procedure to lengthen the intestine, called autologous gastrointestinal reconstruction. Small bowel transplantation (SBT) also may be an option.
  • #1 Short-Bowel Syndrome Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
    https://emedicine.medscape.com/article/193391-treatment
    Most survivors of massive bowel resections who develop short-bowel syndrome (SBS) are initially fed by means of total parenteral nutrition (TPN). In these patients, TPN prevents the development of malnutrition and has been shown to benefit patient outcomes. TPN may be administered concurrently with enteral nutrition early in the clinical course of SBS because the ultimate goal in many of these patients is to enhance intestinal adaptation and render patients free of TPN, as described by Wilmore et al in animal models. […] In many patients, intestinal adaptation, alone or in combination with modified and supplemented diets (eg, growth hormone, glutamine, high carbohydrate, low fat), as described by Byrne et al, eventually allows liberation from TPN. […] TPN is not a panacea. Access sites become infected or the cannulated vein thromboses, necessitating replacement. Eventually, the patient may run out of usable veins through which TPN can be delivered. In addition to these mechanical and infectious complications, many serious metabolic complications are associated with long-term use of TPN. The most clinically important of these are hepatic and biliary derangements.
  • #1 Short-Bowel Syndrome Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
    https://emedicine.medscape.com/article/193391-treatment
    Pharmacologic bowel compensation has had some good results. Better understanding of small-bowel trophic signals and the interaction among foodstuffs, enteric hormones, and the intestinal mucosa might lead to improved bowel adaptation. […] Parenteral nutrition is an important therapy in the care of the patient with SBS. Parenteral nutrition provides adequate protein, calories, other macronutrients, and micronutrients until the bowel has had time to adapt. […] The time required for optimal bowel adaptation is a source of controversy. […] According to Nightingale et al, when enteral nutrient absorption falls to below one third of premorbid capacity, some amount of parenteral nutrition is needed. […] Despite bowel adaptation and meticulous nutritional therapy, some patients cannot be liberated from parenteral nutrition. These patients usually are those with less than 60 cm of small bowel remaining, loss of the ileum and ileocecal valve, and loss of the colon.
  • #1 What Is Short Bowel Syndrome? | SBS
    https://www.shortbowelsyndrome.com/what-is-sbs
    PS is provided intravenously (IV), delivering fluids and/or nutrition directly into a vein. Parenteral support ranges from fluid electrolytes to a complete mix of nutrients. PS can be a lifesaving intervention for some people with SBS, but over the long term it is expensive, affects quality of life, and is associated with serious complications. […] TPN is a type of PS that provides a mixture of proteins, carbohydrates, fats, vitamins, and minerals and is customized to your specific nutrition needs. The liquid nutrients are delivered directly to your bloodstream through a large vein in your chest or arm. It is often used in the first few months following a surgery. […] Tube feeding, also known as enteral nutrition, or EN, delivers nutrients through a feeding tube directly into your stomach or small bowel for those with a partially functioning gastrointestinal (GI) tract. The feeding tubes are passed through the nose, mouth, or skin on your abdomen.
  • #1 Short Bowel Syndrome: What It Is, Who Gets It, and More
    https://www.webmd.com/ibd-crohns-disease/crohns-disease/short-bowel-syndrome
    Whenever possible, the goal will be to get you off of parenteral nutrition since long-term use of it raises risk for serious complications. As you wean off of IV nutrition, you may move to enteral nutrition. That’s when you get food delivered directly to your intestine through a tube. You’ll gradually increase your eating and drinking, which stimulates your intestines and helps them adapt and begin to absorb nutrients as they should. You’ll work with a dietitian to make sure you eat and drink the right things. […] Some people improve but don’t fully recover and need IV nutrition for life. […] Some people need surgery to deal with certain aspects of short bowel syndrome. […] You might need surgery to: […] Put a tube, called a catheter, into a vein so you can get IV nutrition and fluids
  • #1 Short Bowel Syndrome Treatments | Stanford Health Care
    https://stanfordhealthcare.org/medical-conditions/digestion-and-metabolic-health/short-bowel-syndrome/treatments.html
    Our goal is to maximize the functioning of your small intestine with the help of specialized nutrition therapy and other treatments. Using a personalized approach, we have helped patients who were completely dependent on supplemental nutrition go back to eating solid foods in as little as five months. […] When you have SBS, nutrition is an important part of your treatment. Our Digestive Health Center’s dedicated nutritionists specialize in helping patients with SBS get the best nutrition possible through treatments that include: […] Medical nutrition therapy: There is no specific diet for people with SBS. Our experts from Nutrition Services look at many factors to find foods that you like to eat and your stomach can tolerate. We also help you learn important techniques, such as when and how to eat in order to maximize nutrient absorption.
  • #1 Short bowel syndrome: Symptoms, causes, and more
    https://www.medicalnewstoday.com/articles/short-bowel-syndrome
    There are numerous treatment options for SBS. They include: […] Total parenteral nutrition (TPN) involves feeding easy-to-digest solutions with a complete nutritional requirement through a tube directly into the stomach, through an intravenous (IV) line, or both. […] Intestinal adaptation: Doctors gradually reduce and possibly remove a persons reliance on TPN. […] Nutritional help: Adults and children with SBS may need additional supplements to avoid vitamin and mineral deficiencies. […] Medication: The body may not fully absorb oral medication, so doctors may prescribe higher doses than usual. Medications can include: antimotility drugs to slow the action of the intestine down, drugs to help bind unabsorbed bile salts, drugs to reduce gastric acid or the overgrowth of bacteria. […] Surgery: Surgery can help lengthen the small intestine and prevent its blockage. […] Intestinal transplant: Doctors may only recommend this procedure when nothing else has been effective, and the person has serious complications and cannot continue taking in nutrients via TPN.
  • #1 Short-Bowel Syndrome Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
    https://emedicine.medscape.com/article/193391-treatment
    In two clinical trials and two extension studies of patients randomly assigned to receive teduglutide or placebo, those treated with teduglutide achieved 46% and 63% clinical responses, compared with 6% and 30% of those treated with placebo. […] Specific drug therapies in SBS treatment are mainly aimed at decreasing gastric hypersecretion or decreasing diarrhea. […] Diarrhea is a more vexing problem. […] Cases involving patients who have lost all of their colon and ileum, with less than 100 cm of jejunum and an end jejunostomy, are the most difficult to manage. In these patients, the somatostatin analogue octreotide can be administered in doses of 100 g SC q8hr. This can reduce stool output by as much as 50%. […] Operative therapies for SBS can be divided into the following two broad categories: Intestinal or combined liver-intestinal transplantation and Nontransplant operations.
  • #1 Understanding Short Bowel Syndrome & Treatment Options
    https://gastrohealth.com/news/patient-care/what-is-short-bowel-syndrome
    2. Medications 3. Antidiarrheals: loperamide, codeine and diphenoxylate. 4. Antisecretory Agents: ranitidine, omeprazol (decrease acid) or octreotide (reduces fluid loss and slows transit, but slows adaptation process). 5. Antibiotics: decrease bacterial overgrowth that contributes to diarrhea and decrease nutrient absorption (ciprofloxacin, metronidazol or rifaximin). 6. Bile Sequestrants: agents that decrease diarrhea (cholestyramine). E. Growth Factors: agents that promote and enhance adaptation beyond normal limits, increasing intestinal absorptive capacity and decreasing the need for parenteral nutrition support. E.1 Glucagon like peptide-2 (GLP-2): Teduglutide (GattexR), approved by the FDA recently for the treatment of SBS. E.2 Glutamine and Growth Hormone (experimental). F. Supplementation: vitamins such as B12, A, D, E, K and minerals, potassium, chloride, magnesium, calcium, zinc, iron and selenium. Surgical procedures: Refers to specific types of surgical intervention that can contribute to the enhancement of the absorptive surface area and/or decrease in intestinal transient time. Some of them are: 1. In case of intestinal obstructions: lyses of adhesions. B. Reversal of an ostomy (colostomy or ileostomy). 2. Restoration of intestinal continuity. 3. Small bowel transplantation: Only reserved for patients with SBS who are not candidates for parenteral nutrition that have developed complications from it. It is done only in highly specialized centers across the country.
  • #1 Short-Bowel Syndrome Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
    https://emedicine.medscape.com/article/193391-treatment
    The concept of pharmacologic bowel compensation includes measures aimed at further enhancing bowel adaptation and increasing the chances that even patients with difficult cases can be liberated from parenteral nutrition. […] Somatropin is a recombinant human growth hormone that elicits anabolic and anticatabolic influence on various cells (eg, myocytes, hepatocytes, adipocytes, lymphocytes, hematopoietic cells). It exerts activity on specific cell receptors, including insulinlike growth factor-1 (IGF-1). Somatropin is indicated to treat SBS in conjunction with nutritional support. […] Teduglutide, an analogue of naturally occurring glucagonlike peptide-2 (GLP-2), was approved by the FDA in December 2012 for adults with SBS who are dependent on parenteral support and was subsequently approved by the FDA in May 2019 for children as young as 1 year.
  • #1 Medication Options for Short Bowel Syndrome – IFFGD
    https://iffgd.org/gi-disorders/other-disorders/short-bowel-syndrome-2/medication-options/
    In recent years, pharmacological hormonal therapy (the use of hormones in medical treatment) has been introduced aiming to stimulate intestinal adaptation after intestinal resections. Clinical research involving growth hormone, glutamine, and glucagon-like peptide 2 growth hormone (GLP-2) have been studied for the treatment of SBS. […] Teduglutide (Gattex), a recombinant analog of human glucagon-like peptide 2, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with SBS who are dependent on parenteral support. Teduglutide works by regenerating cells in the intestinal lining, improving intestinal absorption of fluids and nutrients, and helping reduce the frequency and volume of parenteral nutrition. […] Apraglutide is a peptide analogue of GLP-2 which is currently under development for treatment of SBS-IF, which acts as a full agonist at the GLP-2 receptor. […] Both of these medications are given by subcutaneous injection.
  • #1 Short Bowel Syndrome Treatments | Stanford Health Care
    https://stanfordhealthcare.org/medical-conditions/digestion-and-metabolic-health/short-bowel-syndrome/treatments.html
    Multivitamins or mineral supplements: Taking multivitamins or mineral supplements can help you replace lost nutrients. […] Supplemental nutrition: Providing extra nutrition through a special formula, supplemental nutrition comes in many forms, including tube feeding. […] Total parenteral nutrition: Getting all the nutrition you need from special fluids you receive through a catheter (thin, spaghetti-like tube) in your vein. Total parenteral nutrition can help you if your intestines need time to heal or your stomach has lost its ability to absorb nutrients from food taken by mouth. […] Other SBS treatments include: […] Medication: Medication can help relieve specific symptoms. This includes anti-diarrheals for diarrhea, which can slow the movement of food through your small intestine, so it has more time to absorb water and nutrients.
  • #1 Short-Bowel Syndrome Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
    https://emedicine.medscape.com/article/193391-treatment
    Nontransplant components of the surgical armamentarium for the treatment of SBS include intestinal lengthening (Bianchi) procedures, intestinal tapering for dilated dysfunctional bowel segments, strictureplasty, and creation of intestinal valves or reversed bowel segments for patients with rapid intestinal transit times. […] Patient selection is paramount to operative success. Nontransplant operative approaches should be tailored to the patient’s remaining length of intestine, the presence or absence of strictures or areas of stasis, the degree of bowel dilatation, and the intestinal transit time, as described above. […] Transplant surgery is usually reserved for patients who are dependent on parenteral nutrition, who have run out of venous access, who have had several episodes of central line-related sepsis, or who have begun to manifest progressive parenteral nutrition-associated liver dysfunction.
  • #1 Short-Bowel Syndrome: Practice Essentials, Anatomy, Pathophysiology
    https://emedicine.medscape.com/article/193391-overview
    Numerous nontransplant operative approaches have been used in the treatment of patients with SBS. Such approaches include intestinal lengthening (Bianchi) procedures, intestinal tapering for dilated dysfunctional bowel segments, strictureplasty, and creation of intestinal valves or reversed bowel segments for patients with rapid intestinal transit times. […] Organ (eg, intestinal or hepatic-intestinal) transplantation was a later addition to surgical treatment of this syndrome. Transplant surgery is usually reserved for patients who are dependent on parenteral nutrition, who have run out of venous access, who have had several episodes of central linerelated sepsis, or who have begun to manifest progressive parenteral nutritionassociated liver dysfunction. These patients should be identified early and transplant performed before hepatic cirrhosis develops. […] The American Gastroenterological Association (AGA) has published best practice advice on the management of SBS.
  • #1 Short Bowel Syndrome | Doctor
    https://patient.info/doctor/short-bowel-syndrome
    In general, surgery is indicated as a last resort when all other therapeutic options, including parenteral and enteral feeding and pharmacological bowel compensation, have been tried. […] Various procedures have been tried to a greater or lesser degree of success. These include connecting residual small bowel to the colon to maintain intestinal integrity, intestinal lengthening and tailoring (the Bianchi procedure), tapering for dilated segments, strictureplasty, creation of intestinal valves or reversed bowel segments to reduce rapid transit time. […] Isolated intestinal transplantation: this is mainly indicated for patients who have reasonable liver function or significant liver disease that has not progressed to cirrhosis. It may also be appropriate for patients who have significant fluid losses and who have episodes of frequent, severe dehydration despite appropriate medical management. […] Combined intestinal and organ transplantation: this is indicated for patients with SBS and end-stage liver failure. Renal transplantation may also be combined in appropriate patients.
  • #1 Short-Bowel Syndrome Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
    https://emedicine.medscape.com/article/193391-treatment
    The most frequent manifestation of hepatobiliary disease in patients with SBS who are on TPN is cholestasis. […] Progressive hepatic parenchymal damage is the most feared hepatobiliary complication of prolonged TPN. Fatty liver is often observed in adults. Nonalcoholic steatohepatitis has features of fatty change but is associated with inflammatory cell infiltration and fibrosis. […] The decision to operate on a patient with SBS requires great judgment. Surgery is undertaken in these patients usually only after all other therapeutic options, such as parenteral and enteral nutrition or pharmacologic bowel compensation, have been exhausted. […] Future developments in the treatment of SBS will consist of finding ways to maximize bowel adaptation and of refining techniques of transplantation and immune modulation.
  • #1 Tissue engineering for the treatment of short bowel syndrome in children | Pediatric Research
    https://www.nature.com/articles/pr2017234
    Short bowel syndrome is a major cause of morbidity and mortality in children. […] current therapy is primarily supportive. Definitive treatment often requires intestinal transplantation, which is associated with significant morbidity and mortality. […] the development of an artificial intestine derived from the patients own intestinal stem cells and incorporated into a novel bioscaffold that recruits an endogenous blood supply may represent an attractive option for the treatment of children with SBS. […] Present treatment options focus on either increasing absorption (via adaptation and intestinal reversal procedures) or restoring intestinal length (via intestinal-lengthening procedures and transplant.). […] Given the limited success and high morbidity of current therapy, novel treatment approaches are clearly needed.
  • #1 Short bowel syndrome: how can gene and cell therapy help? | EuroGCT
    https://www.eurogct.org/short-bowel-syndrome-how-can-gene-and-cell-therapy-help
    For example, Nikhil Thapars laboratory at UCL has looked at ways to use stem cells to rebuild parts of the intestinal nervous system, which could treat individuals suffering from an enteric neuropathy (failure of the gut nervous system, sometimes also called Intestinal pseudoobstruction). Treatments that rebuild the intestines nervous system would greatly help prevent surgeries that lead to SBS. […] Researchers are also using stem cells and patient tissue to grow small intestine organoids (meaning organ-resembling). […] In cases where surgeries to remove the small intestine are unavoidable, stem cell transplants may be able to help repair the intestine after surgery and regrow some of the cells and tissue that has been lost. Alternatively, researchers part of the international collaborative INTENS project are examining how stem cells might be used to grow new segments of intestine on biological scaffolds that can be transplanted.
  • #1 Short Bowel Syndrome Treatment | Surgery | Stanford Medicine
    https://surgery.stanford.edu/news/SBS-Treatment.html
    Treatment for Short Bowel Syndrome Applies for Human Trial Approval […] Stanford University Chief of Pediatric Surgery James Dunn, MD, is applying to the U.S. Food and Drug Administration (FDA) to start human trials on his distraction enterogenesis-inducing endoluminal coils. […] Dr. Dunns springs are intended to treat children with short bowel syndrome, a condition that affects 3,000 children in the U.S. every year and that for which there is no definitive cure. […] Short bowel syndrome is a devastating disease with few viable treatments that meaningfully restore quality of life for children affected with this disease, said Department of Surgery Chair Dr. Mary Hawn. A device solution, such as the one developed by Dr. Dunn will expand the capacity of the native gut. This is truly innovative, will drastically improve the outcomes and quite simply will save lives.
  • #1 Management of short bowel syndrome (SBS) – American Gastroenterological AssociationAGA Logo_Horizontal
    https://gastro.org/clinical-guidance/management-of-short-bowel-syndrome-sbs/
    Experts provide 12 best practices for the management of short bowel syndrome (SBS). […] 1. Bowel anatomy […] 2. Nutrition assessment […] 3. Diet […] 4. Parenteral nutrition (PN) […] 5. Oral rehydration solution […] 6. Pharmacologic therapy […] 7. Drug dosing […] 8. Surgery […] 9. Glucagon-like-peptide-2 (GLP-2) […] 10. Prevention of complications […] 11. Referral for intestinal transplantation (ITX) […] 12. Education and support for patients and caregivers.
  • #1 Short Bowel Syndrome Therapy and Rehabilitation (STAR) Program | Memorial Hermann
    https://memorialhermann.org/services/conditions/pediatric-short-bowel-syndrome
    Children with short bowel syndrome do not have the intestinal length necessary to properly eat and grow and must be treated to ensure they receive the nutrition they need. […] Short bowel syndrome requires a dedicated, multidisciplinary team to rehabilitate the intestine with specialized nutrition support, medical management strategies and surgical therapy. […] Treatment for short-bowel syndrome depends on the underlying cause and the severity of the condition. Patients in the STAR program often receive nutritional support, medical management and surgery. […] Specialized Nutritional Support includes parenteral nutrition (intravenous nutrition), lipid-minimization protocols and new-generation intravenous lipid emulsions (IVLE) to limit parenteral nutrition-associated liver disease (PNALD) or intestinal failure-associated liver disease (IFALD), enteral nutrition (tube feedings), and early initiation of oral feeding to avoid oral aversion.
  • #1 The Clinician’s Toolkit for the Adult Short Bowel Patient Part I: Nutrition and Hydration Therapy – Practical Gastro
    https://practicalgastro.com/2022/08/03/the-clinicians-toolkit-for-the-adult-short-bowel-patient-part-i-nutrition-and-hydration-therapy/
    The patient must be informed of not only what they need to avoid, but more importantly, what they can eat, and the amount and frequency of meals and snacks. […] Expertise in the SBS diet highlights the role of the dietitian as an invaluable team member to these patients. […] The best defense against kidney stone formation is to flush the oxalate through the urinary tract by maintaining a urine output 1500 mL/day. […] Many SBS patients will require vitamin and mineral supplementation throughout their lifetime. […] Maintaining both nutrition and hydration status are central components to the care of patients with SBS.
  • #1 SciELO Brazil – Short bowel syndrome: treatment options Short bowel syndrome: treatment options
    https://www.scielo.br/j/jcol/a/bQSzfX9kHHDvFXvWWQxwJmJ/
    Several therapies, including nutritional support, pharmacological options and surgical procedures have been used in these patients. […] Over the last decades new surgical and pharmacological approaches emerged, increasing survival and quality of life (QoL) in patients with SBS. All SBS patients ought to have an individualized and multidisciplinary care that promotes intestinal rehabilitation. […] The established treatment occurs at a nutritional, pharmacological or, if necessary, surgical level. […] The patients in the postoperative period begin with PN (at least in the first 7-10 days) as a way to ensure a proper nutrition until there is hemodynamic stabilization with a switch whenever is possible, to enteral nutrition (EN) and later to an oral diet. […] The established plan (PN or EN), as well as the composition, volume of the formulation, and number of infusions should be adjusted to individual needs.
  • #1 Targeted therapy of short-bowel syndrome with teduglutide: the new kid | CEG
    https://www.dovepress.com/targeted-therapy-of-short-bowel-syndrome-with-teduglutide-the-new-kid–peer-reviewed-fulltext-article-CEG
    Teduglutide, a recombinant analog of glucagon-like peptide-2, is the first targeted therapeutic agent to gain approval for use in adult SBS-IF. […] Teduglutide was shown to result in significant (20%100%) reduction in PS-volume requirement and have a satisfactory safety profile in three randomized control trials. […] A coordinated care approach by a multidisciplinary team of gastroenterologists, surgeons, pharmacists, dieticians, and nurses is crucial for successful intestinal rehabilitation. […] Treatment strategies are individually tailored, with titration of medication dose and frequency and PS volume and constitution guided by the patients clinical and laboratory markers of fluid and nutritional balance. […] Teduglutide has been approved by the FDA since December 2012 under the trade name of Gattex, and by the European Medicines Agency since June 2012, where it is marketed as Revestive.
  • #1 Surgical Treatment of Short Bowel Syndrome—The Past, the Present and the Future, a Descriptive Review of the Literature
    https://www.mdpi.com/2227-9067/9/7/1024
    Short bowel syndrome (SBS) is a devastating disorder with both short- and long-term implications for patients. […] As of yet, no cure exists, thus, conservative treatment, primarily parenteral nutrition (PN), is the first-line therapy. In some cases, weaning from PN is not possible and operative therapy is required. […] With this review, we aim to provide an overview of the clinical implications of SBS, common conservative therapies and the development of operative techniques over the past six decades. […] The ultimate goal of SBS treatment is to achieve full intestinal autonomy and to reduce long-term dependence on parenteral support by increasing the absorptive capacity of the remnant bowel. […] Current therapeutic approaches follow a sequential strategy. The first-line therapy consists of parenteral nutrition, promotion of enteral feeding, restoration of bowel continuity, closure of enterostomies as early as possible, the use of dietary supplementations and, where indicated, antibiotics.
  • #2 Short Bowel Syndrome – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK536935/
    Short bowel syndrome (SBS) in adults is defined as less than 180 to 200 centimeters of remaining small bowel leading to the need for nutritional and fluid supplements. […] Patients are managed using either lifelong parenteral nutrition or intestinal transplantation. […] Outline the treatment of short bowel syndrome. […] Initial management of SBS involves maintaining good nutritional status, maximizing the absorptive surface area of the remaining intestine, and preventing complications. This involves early postoperative parenteral nutrition as well as enteral nutrition once the patient’s ileus has resolved. This promotes intestinal adaptation which improves absorption of nutrients over time. […] Those patients in whom intestinal failure is irreversible will require either lifelong home parenteral nutrition or intestinal transplantation if a life-threatening complication of either SBS or home parenteral nutrition arises. Treatment of SBS, therefore, largely consists of managing and preventing complications that arise as a direct result of SBS or secondarily to home parenteral nutrition.
  • #2 Short Bowel Syndrome Treatments | Stanford Health Care
    https://stanfordhealthcare.org/medical-conditions/digestion-and-metabolic-health/short-bowel-syndrome/treatments.html
    Our goal is to maximize the functioning of your small intestine with the help of specialized nutrition therapy and other treatments. Using a personalized approach, we have helped patients who were completely dependent on supplemental nutrition go back to eating solid foods in as little as five months. […] When you have SBS, nutrition is an important part of your treatment. Our Digestive Health Center’s dedicated nutritionists specialize in helping patients with SBS get the best nutrition possible through treatments that include: […] Medical nutrition therapy: There is no specific diet for people with SBS. Our experts from Nutrition Services look at many factors to find foods that you like to eat and your stomach can tolerate. We also help you learn important techniques, such as when and how to eat in order to maximize nutrient absorption.
  • #2 Short Bowel Syndrome: What It Is, Who Gets It, and More
    https://www.webmd.com/ibd-crohns-disease/crohns-disease/short-bowel-syndrome
    Put a feeding tube in your stomach or small intestine to give you enteral nutrition […] Fix or remove other damage or problems in your intestines […] Make your intestine longer or change its structure so it can work better […] Get an intestinal transplant in serious cases when your intestines don’t return to proper function, you need long-term IV nutrition, and you develop serious complications. […] Medicine will play a role in your care, too. You might receive one or more of the following: […] Teduglutide (Gattex). This medicine might improve the structure and function of your intestine as it adapts so that it can absorb nutrients and reduce your need for IV nutrition. […] Somatropin (Genotropin, Humatrope, Norditropin, Nutropin, Serostim, Zorbtive). A human-made form of human growth hormone, a substance given off by your pituitary gland, that can help your intestines absorb better.
  • #2 Short-Bowel Syndrome Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
    https://emedicine.medscape.com/article/193391-treatment
    Pharmacologic bowel compensation has had some good results. Better understanding of small-bowel trophic signals and the interaction among foodstuffs, enteric hormones, and the intestinal mucosa might lead to improved bowel adaptation. […] Parenteral nutrition is an important therapy in the care of the patient with SBS. Parenteral nutrition provides adequate protein, calories, other macronutrients, and micronutrients until the bowel has had time to adapt. […] The time required for optimal bowel adaptation is a source of controversy. […] According to Nightingale et al, when enteral nutrient absorption falls to below one third of premorbid capacity, some amount of parenteral nutrition is needed. […] Despite bowel adaptation and meticulous nutritional therapy, some patients cannot be liberated from parenteral nutrition. These patients usually are those with less than 60 cm of small bowel remaining, loss of the ileum and ileocecal valve, and loss of the colon.
  • #2 Short Bowel Syndrome | Doctor
    https://patient.info/doctor/short-bowel-syndrome
    Interventions that may improve quality of life among patients dependent on parenteral nutrition and their carers include patient education, affiliation with support groups, treatment of concomitant symptoms and pharmacotherapies that decrease parenteral nutrition requirements. […] Most patients are treated with total parenteral nutrition (TPN) in the early stages. A decision is then taken as to whether the patient needs limited specialised enteral therapy or prolonged TPN. This will depend on the length and function of the remaining intestine and the mechanisms influencing transit time, including the functioning of the ileocaecal valve and colon. A combination of TPN and enteral feeding is often tried as this facilitates the discontinuation of TPN at the earliest possible stage. […] Parenteral nutrition should provide adequate protein, calories, macronutrients and micronutrients. The time for adaptation, when improved absorption occurs, is controversial. Some authorities hold that maximal adaptation can take up to a year, others that little improvement is to be obtained after three months.
  • #2 Short Bowel Syndrome – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/malabsorption-syndromes/short-bowel-syndrome
    Short bowel syndrome is malabsorption resulting from extensive resection of the small bowel (usually more than two-thirds the length of the small intestine). Treatment is with small feedings, antidiarrheals, and sometimes total parenteral nutrition or intestinal transplantation. […] Total parenteral nutrition (TPN) […] Patients typically require TPN and intensive monitoring of fluid and electrolytes (including calcium and magnesium). […] Patients with extensive resection (100 cm of remaining small bowel) and those with excessive fluid and electrolyte losses require TPN for life. […] Patients with 100 cm of remaining jejunum can achieve adequate nutrition through oral feeding. […] Patients who have diarrhea after meals should take antidiarrheals (eg, loperamide) 1 hour before eating.
  • #2 What Is Short Bowel Syndrome? | SBS
    https://www.shortbowelsyndrome.com/what-is-sbs
    Tube feeding helps stimulate your digestive process and provides nutrients at a much slower rate than food taken orally. It can help maintain or improve the absorptive power of your remaining bowel, potentially offering enough nutrients and fluid to avoid the use of total parenteral nutrition. Enteral nutrition is commonly used in children with SBS. […] If adaptation is not enough to meet a persons nutrient needs, they will need to depend on ongoing parenteral support, which delivers a mix of nutrients, electrolytes, and calories.
  • #2 Diagnosis and Treatment of Pediatric Short Bowel Syndrome and Intestinal Failure | NewYork-Presbyterian
    https://www.nyp.org/pediatrics/digestive-diseases/short-bowel-syndrome-and-intestinal-failure/diagnosis-and-treatment
    Enteral nutrition includes formula or blenderized foods that are delivered to the stomach or small intestine through a feeding tube (i.e., gastrostomy tube or gastrojejunostomy tube) […] Many children receiving enteral nutrition are also encouraged to eat small amounts of breast milk, formula, or food by mouth. This supports normal development of chewing, sucking, and swallowing. Feeding and occupational therapists support children as they learn to eat by mouth. […] Oral nutrition is individualized for your child to encourage foods that are easily digested and absorbed and discourage foods that worsen diarrhea. Our ultimate goal is for your child to be able to eat and absorb oral nutrients on their own. […] Your child’s pediatric surgeon will participate in your child’s team visits and will consider possible restorative surgeries that reshape the intestine to make it more functional. New York-Presbyterian Morgan Stanley Children’s Hospital is one of a few hospitals in the country to offer the serial transverse enteroplasty procedure (STEP), in which the small intestine is surgically reshaped to increase surface area and lengthen the amount of time it takes for food to move through it, increasing absorption of nutrients.
  • #2 Understanding Short Bowel Syndrome & Treatment Options
    https://gastrohealth.com/news/patient-care/what-is-short-bowel-syndrome
    1. Enteral feeding: Should be introduced as soon as possible to promote intestinal adaptation since it stimulates release of digestive juices, hormonal secretions and maintains the integrity of the gut barrier and its inmmunoregulatory mechanisms. The goal is to taper parenteral nutrition and slowly start oral feedings. Initially, an elemental diet in continuous fashion increases absorption of lipids, proteins and net energy. Later on, a complex diet also in a continuous fashion promotes and facilitates intestinal adaptation thereby accelerating progression to oral feedings. Bolus feeding should be introduced slowly and progressively. Patients tend to tolerate complex carbohydrates much better than simple ones as well as fatty food. Ideally, nutrition should be frequent (every 2- 3 hours), balanced with proteins, carbohydrates, with lipids (40% at least) and without hypertonic beverages (sodas or juices) or high carbohydrate feedings.
  • #2 How to Manage Short Bowel Syndrome
    https://www.everydayhealth.com/crohns-disease/symptoms/how-manage-short-bowel-syndrome/
    Ideally, you’ll want to see a GI dietitian with experience with short bowel syndrome to determine the appropriate diet to meet your macro- and micronutrient needs, Paski says. […] It’s important to reintroduce food slowly after bowel resection surgery, with small, nutritious, and frequent meals throughout the day. Focus on getting enough protein and complex carbohydrates, while avoiding foods that are high in fat and sugar. It’s also best to drink most of your liquids between rather than with meals, since drinking beverages with meals can speed up digestion in a way that limits nutrient absorption and increases diarrhea, according to the Crohns Colitis Foundation. […] In addition to dietary changes, you may also need to take vitamin or mineral supplements to meet your daily nutritional needs.
  • #2 Managing the Adult Patient With Short Bowel Syndrome – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/october-2017/managing-the-adult-patient-with-short-bowel-syndrome/
    The care of SBS requires the use of a variety of treatments. Thus, a multidisciplinary approach consisting of physicians, surgeons, dietitians, nurses, and social workers experienced in the care of patients with intestinal failure is helpful for the optimal management of this patient population. […] Diet therapy is an important intervention not only for the sake of nourishment, but also as a means for affecting intestinal adaptation and symptom control. […] The hydration status is often neglected in the SBS patient population. However, fluid and electrolyte abnormalities are a major cause of morbidity and hospitalization in patients with ostomies. […] Treatment of SBS requires aggressive use of several medications. […] Conventional medications used for SBS are essential for symptom relief. The most commonly used medications, particularly during the period of greatest intestinal adaptation, are antisecretory and antimotility agents.
  • #2 Advice for people with short bowel syndrome – Newcastle Hospitals NHS Foundation Trust
    https://www.newcastle-hospitals.nhs.uk/resources/advice-for-people-with-short-bowel-syndrome/
    You may need to have fluids given via a vein, this is called intravenous fluid. […] You may also need to have nutrients and calories given via a vein if you cannot absorb enough nutrients from your bowel and you are losing weight. This is called parenteral nutrition. Your fluid and diet will be discussed and tailored to you by the dietitian. […] The following medications are prescribed to help to reduce stoma output: Loperamide – take this at least 30 minutes before food. […] You may need additional medications or supplements including: Magnesium, Calcium/Vitamin D, Iron, Vitamin B12 injections (hydroxocobalamin), Multivitamins. […] Your pharmacist/clinical team will advise on the dose and frequency of these medications.
  • #2 How to Manage Short Bowel Syndrome
    https://www.everydayhealth.com/crohns-disease/symptoms/how-manage-short-bowel-syndrome/
    Some people have such severe SBS that they need medically supported nutrition, administered either with an IV (parenteral nutrition) or through a tube that carries food into your stomach (enteral nutrition), according to the American Gastroenterological Association. […] To address your symptoms, your doctor may also prescribe the following treatments, according to NIDDK: H2 blockers or proton pump inhibitors, to treat excess stomach acid secretion; Antidiarrheal medicines, such as Imodium (loperamide); Oral rehydration solutions to treat dehydration; Growth hormones, like Gattex (teduglutide), to help your intestine take in more fluids and nutrients; Antibiotics to treat or prevent bacterial overgrowth in your small intestine; Choleretic agents to improve the flow of bile (a digestive fluid) and help prevent liver disease; Hypomotility drugs to increase the amount of time it takes for food to travel through your intestines.
  • #2 Understanding Short Bowel Syndrome & Treatment Options
    https://gastrohealth.com/news/patient-care/what-is-short-bowel-syndrome
    2. Medications 3. Antidiarrheals: loperamide, codeine and diphenoxylate. 4. Antisecretory Agents: ranitidine, omeprazol (decrease acid) or octreotide (reduces fluid loss and slows transit, but slows adaptation process). 5. Antibiotics: decrease bacterial overgrowth that contributes to diarrhea and decrease nutrient absorption (ciprofloxacin, metronidazol or rifaximin). 6. Bile Sequestrants: agents that decrease diarrhea (cholestyramine). E. Growth Factors: agents that promote and enhance adaptation beyond normal limits, increasing intestinal absorptive capacity and decreasing the need for parenteral nutrition support. E.1 Glucagon like peptide-2 (GLP-2): Teduglutide (GattexR), approved by the FDA recently for the treatment of SBS. E.2 Glutamine and Growth Hormone (experimental). F. Supplementation: vitamins such as B12, A, D, E, K and minerals, potassium, chloride, magnesium, calcium, zinc, iron and selenium. Surgical procedures: Refers to specific types of surgical intervention that can contribute to the enhancement of the absorptive surface area and/or decrease in intestinal transient time. Some of them are: 1. In case of intestinal obstructions: lyses of adhesions. B. Reversal of an ostomy (colostomy or ileostomy). 2. Restoration of intestinal continuity. 3. Small bowel transplantation: Only reserved for patients with SBS who are not candidates for parenteral nutrition that have developed complications from it. It is done only in highly specialized centers across the country.
  • #2 Short Bowel Syndrome – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/malabsorption-syndromes/short-bowel-syndrome
    Cholestyramine 2 to 4 g taken with meals reduces diarrhea associated with bile acid malabsorption due to ileal resection. […] Monthly IM injections of vitamin B12 should be given to patients with a documented deficiency. […] Most patients should take supplemental vitamins, calcium, and magnesium. […] Gastric acid hypersecretion can develop, which can deactivate pancreatic enzymes; thus, most patients are given proton pump inhibitors. […] Small-bowel transplantation is advocated for patients who are not candidates for long-term TPN and in whom adaptation does not occur. […] Patients 1 year of age who require parenteral support may benefit from teduglutide or apraglutide (glucagon-like peptide-2 [GLP-2] analogs). […] Antidiarrheals, cholestyramine, proton pump inhibitors, and vitamin supplements are needed.
  • #2 Surgical Treatment of Short Bowel Syndrome—The Past, the Present and the Future, a Descriptive Review of the Literature
    https://www.mdpi.com/2227-9067/9/7/1024
    Since its advent in the late 1960s, PN represents a cornerstone in the conservative treatment of SBS patients. […] The ESPGHAN/ESPEN/ESPR/CSPEN guidelines also provide recommendations on complications, fluid and electrolytes, iron and trace minerals, calcium, phosphorus and magnesium, home parenteral nutrition and organizational aspects in PN. […] The focus of medical treatment is to compensate for fluid, electrolyte and nutrient losses, to limit diarrhea and promote adequate weight gain and growth. […] The first-line therapy for diarrhea is antimotility agents such as loperamide or diphenoxylate-atropine. […] The American College of Gastroenterologists (ACG) recommends antibiotic treatment for SIBO in order to eradicate overgrowth and resolve symptoms, citing a meta-analysis of 24 cohort studies, 7 randomized controlled trials (RCTs) and 1 randomized crossover study showing rifaximin is effective and safe for treating SIBO.
  • #2 Medication Options for Short Bowel Syndrome – IFFGD
    https://iffgd.org/gi-disorders/other-disorders/short-bowel-syndrome-2/medication-options/
    In recent years, pharmacological hormonal therapy (the use of hormones in medical treatment) has been introduced aiming to stimulate intestinal adaptation after intestinal resections. Clinical research involving growth hormone, glutamine, and glucagon-like peptide 2 growth hormone (GLP-2) have been studied for the treatment of SBS. […] Teduglutide (Gattex), a recombinant analog of human glucagon-like peptide 2, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with SBS who are dependent on parenteral support. Teduglutide works by regenerating cells in the intestinal lining, improving intestinal absorption of fluids and nutrients, and helping reduce the frequency and volume of parenteral nutrition. […] Apraglutide is a peptide analogue of GLP-2 which is currently under development for treatment of SBS-IF, which acts as a full agonist at the GLP-2 receptor. […] Both of these medications are given by subcutaneous injection.
  • #2 GATTEX® (teduglutide) for Short Bowel Syndrome (SBS)
    https://www.gattex.com/
    For people 1 year of age and older with SHORT BOWEL SYNDROME (SBS) who are dependent on parenteral support (PS) […] GATTEX (teduglutide) for subcutaneous injection is a prescription medicine used in adults and children 1 year of age and older with Short Bowel Syndrome (SBS) who need additional nutrition or fluids from intravenous (IV) feeding (parenteral support). […] Individual results may vary. *In a 6-month study, 18 out of 26 children (aged 1 to 17) treated with GATTEX reduced weekly PS volume by 20% or more and 10 out of 26 achieved a reduction of at least 1 day off PS per week. […] To keep using GATTEX, your healthcare provider should have your colon checked for new polyps at the end of 1 year of using GATTEX. If no polyp is found, your healthcare provider should check you for polyps as needed and at least every 5 years.
  • #2 Short Bowel Syndrome | Doctor
    https://patient.info/doctor/short-bowel-syndrome
    A recombinant analog of glucagon-like peptide-2 (teduglutide) has been shown to result in a significant reduction in the requirement of intravenous fluids/parenteral nutrition. The National Institute for Health and Care Excellence (NICE) has recommended teduglutide as an option for treating SBS in people aged over 1 year, where it is provided under a commercial agreement. […] The treatment of SBS has to be individualised according to the clinical status of individual patients, and the decision on whether to resort to surgery and what operation to perform, depends upon many factors. […] For patients with SBS, surgery can play an important role in preventing, mitigating, and, in some cases, reversing intestinal failure. There are several surgical options for management, including construction of intestinal valves or reversed intestinal segments, interposition of segments of colon, or intestinal lengthening procedures.
  • #2 Short-Bowel Syndrome: Practice Essentials, Anatomy, Pathophysiology
    https://emedicine.medscape.com/article/193391-overview
    Numerous nontransplant operative approaches have been used in the treatment of patients with SBS. Such approaches include intestinal lengthening (Bianchi) procedures, intestinal tapering for dilated dysfunctional bowel segments, strictureplasty, and creation of intestinal valves or reversed bowel segments for patients with rapid intestinal transit times. […] Organ (eg, intestinal or hepatic-intestinal) transplantation was a later addition to surgical treatment of this syndrome. Transplant surgery is usually reserved for patients who are dependent on parenteral nutrition, who have run out of venous access, who have had several episodes of central linerelated sepsis, or who have begun to manifest progressive parenteral nutritionassociated liver dysfunction. These patients should be identified early and transplant performed before hepatic cirrhosis develops. […] The American Gastroenterological Association (AGA) has published best practice advice on the management of SBS.
  • #2 Short Bowel Syndrome | Doctor
    https://patient.info/doctor/short-bowel-syndrome
    In general, surgery is indicated as a last resort when all other therapeutic options, including parenteral and enteral feeding and pharmacological bowel compensation, have been tried. […] Various procedures have been tried to a greater or lesser degree of success. These include connecting residual small bowel to the colon to maintain intestinal integrity, intestinal lengthening and tailoring (the Bianchi procedure), tapering for dilated segments, strictureplasty, creation of intestinal valves or reversed bowel segments to reduce rapid transit time. […] Isolated intestinal transplantation: this is mainly indicated for patients who have reasonable liver function or significant liver disease that has not progressed to cirrhosis. It may also be appropriate for patients who have significant fluid losses and who have episodes of frequent, severe dehydration despite appropriate medical management. […] Combined intestinal and organ transplantation: this is indicated for patients with SBS and end-stage liver failure. Renal transplantation may also be combined in appropriate patients.
  • #2 Diagnosis and Treatment of Pediatric Short Bowel Syndrome and Intestinal Failure | NewYork-Presbyterian
    https://www.nyp.org/pediatrics/digestive-diseases/short-bowel-syndrome-and-intestinal-failure/diagnosis-and-treatment
    At New York-Presbyterian Morgan Stanley Children’s Hospital, we offer intestinal and multi-visceral organ transplantation to children when other treatment strategies have failed or are not possible. Our specialists perform isolated small intestine transplantation in children with intestinal failure who have a functioning liver and offer combined liver and intestinal transplantation for patients with both liver and intestinal failure.
  • #2 How to Manage Short Bowel Syndrome
    https://www.everydayhealth.com/crohns-disease/symptoms/how-manage-short-bowel-syndrome/
    Some people with SBS need surgery, which may be done to increase your small intestines ability to absorb nutrients, prevent blockages, increase the surface area of the small intestine, or narrow any area that is too wide. About half of all people with SBS need surgery to treat the condition, according to NIDDK. […] In cases where other treatments haven’t worked, an intestinal transplant may be performed. This procedure involves removing a diseased small intestine and replacing it with a healthy one from someone who has just died. It may also be possible for a living person to donate a portion of their small intestine. […] Because of the risks involved, intestinal transplants are typically reserved for people who have developed complications that don’t allow them to continue receiving total parenteral nutrition, Paski says. Complications of intestinal transplant may include greater susceptibility to infection and rejection of the transplanted intestine. […] But the procedure can be lifesaving for people with SBS who experience intestinal failure. Your doctor can discuss whether or not an intestinal transplant is an option for you.
  • #2 Short bowel syndrome: how can gene and cell therapy help? | EuroGCT
    https://www.eurogct.org/short-bowel-syndrome-how-can-gene-and-cell-therapy-help
    From drugs to surgical methods and stem cells to growing synthetic intestines in a lab, all aspects and methods for treating SBS are being examined. […] Some research aims to prevent SBS, by exploring treatments (including stem cell treatments) for intestinal diseases before removing sections of intestine is required. […] Surgical methods to treat SBS are being explored, such as introducing valves to the small intestine to slow down the passage of food. Methods for treating SBS include research into drugs and hormones such as Teduglutide, which promote intestinal cells to absorb more water and nutrients. […] Many of the research areas surrounding the treatment of SBS are actively interested in stem cells. Stem cells offer opportunities to repair, heal and regrow sections of the small intestine, but using them requires years of research to understand the basics of how stem cells work as well as how they might help treat diseases.
  • #2 Tissue engineering for the treatment of short bowel syndrome in children | Pediatric Research
    https://www.nature.com/articles/pr2017234
    The goals of developing an artificial intestine include the provision of appropriate absorptive epithelium, barrier and immune functions, and motility. […] A successful bioscaffold will require the following features: a material capable of supporting stem cell attachment, proliferation, and differentiation; support of angiogenesis and vascular ingrowth; approximation of mechanical and electrical properties of the intestine so as to facilitate operative insertion, and incorporation without an excessive acute inflammatory or chronic immune response. […] The production of an effective and biocompatible scaffold on which cells can grow and be transplanted as a graft is a critical step in the development of artificial intestine. […] Vascularization is a critical step in the production of an artificial intestine.
  • #2 A revolutionary way of treating Short Bowel Syndrome | Research and Innovation
    https://projects.research-and-innovation.ec.europa.eu/en/projects/success-stories/all/revolutionary-way-treating-short-bowel-syndrome
    Short Bowel Syndrome is a medical disorder without a cure and with limited treatment options. […] Unfortunately, there is no cure for SBS, and current treatment options have low survival rates and can cause serious side-effects especially for children. […] Our aim is to deliver a functional small bowel that could be used to treat patients with SBS, says Paolo De Coppi, National Institute for Health Research professor of paediatric surgery at the UCL Great Ormond Street Institute of Child Health and INTENS project coordinator. […] Today, treating SBS requires long-term parenteral nutrition (nutrition provided through the vein) or an organ transplant. […] To overcome this challenge, the INTENS project focused on developing a strategy for autologous tissue engineering or the process of treating an individual using their own cells or tissues.
  • #2 Short Bowel Syndrome Treatment | Surgery | Stanford Medicine
    https://surgery.stanford.edu/news/SBS-Treatment.html
    As the disease affects fewer than 200,000 people in the United States, Dr. Dunn is applying for a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA). […] Normally when you want to test a new device you have you go through very complicated, expensive process of clinical trials, said Dr. Dunn. With an HDE, we can go through a shortened phase of clinical testing. […] Dr. Dunns proposal was unanimously approved with strong support by the review team. […] Even if Dr. Dunn is approved for the HDE, the shorted clinical trial consisting of 5-10 patients will cost approximately $2 million. […] Because the market is small, big companies dont want to take it on, said Dr. Dunn. In these cases, we rely on philanthropic donations, people who are willing to donate money for the good of the patients.
  • #2 Intestinal Failure & Rehabilitation | UI Health
    https://hospital.uillinois.edu/primary-and-specialty-care/transplantation-program/small-bowel-transplantation/intestinal-failure-and-rehabilitation
    UI Health is a worldwide leader in medical and surgical treatment of disorders and disease of the small bowel and intestines. Our comprehensive team of gastroenterologists, transplant surgeons, nurses, dietitians, pharmacists, social workers, and psychologists works to ensure the best possible patient care, from diagnostic procedures to intestinal rehabilitation and small bowel transplantation. […] The Intestinal Rehabilitation and Transplantation Program at UI Health specializes in diagnosing and treating malabsorption disorders, short bowel syndrome, and intestinal failure. […] Malabsorption conditions like short bowel syndrome and long-term parenteral nutrition can result in complications like liver disease and recurrent infection. Our doctors specialize in medical, surgical, and rehabilitation treatments to prevent and manage life-threatening complications, should they occur.
  • #2 Short-Bowel Syndrome Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
    https://emedicine.medscape.com/article/193391-treatment
    The most frequent manifestation of hepatobiliary disease in patients with SBS who are on TPN is cholestasis. […] Progressive hepatic parenchymal damage is the most feared hepatobiliary complication of prolonged TPN. Fatty liver is often observed in adults. Nonalcoholic steatohepatitis has features of fatty change but is associated with inflammatory cell infiltration and fibrosis. […] The decision to operate on a patient with SBS requires great judgment. Surgery is undertaken in these patients usually only after all other therapeutic options, such as parenteral and enteral nutrition or pharmacologic bowel compensation, have been exhausted. […] Future developments in the treatment of SBS will consist of finding ways to maximize bowel adaptation and of refining techniques of transplantation and immune modulation.
  • #2 Short Bowel Syndrome Therapy and Rehabilitation (STAR) Program | Memorial Hermann
    https://memorialhermann.org/services/conditions/pediatric-short-bowel-syndrome
    Medical Management Strategies include ethanol-lock and sodium bicarbonate-lock protocols to decrease the incidence of central line-associated blood stream infections (CLABSIs) and telemedicine visits. […] Surgical Therapy includes early restoration of intestinal continuity (ostomy takedown with intestinal reconnection) and bowel lengthening procedures, such as the serial transverse enteroplasty procedure (STEP).
  • #2 Mental Health & Short Bowel – Short Bowel Foundation
    https://shortbowelfoundation.org/mental-health-short-bowel-syndrome/
    The treatment of SBS involves a multidisciplinary approach, considering both medical and nutritional interventions. Maintaining a balance in nutrient absorption, addressing hormonal imbalances, and managing symptoms contribute to the overall management of the condition. […] Its important for individuals with short bowel syndrome to work closely with healthcare professionals, including dietitians and mental health experts, to address both the physical and emotional aspects of the condition. Nutritional support, counseling, and medication adjustments may be part of a comprehensive care plan to improve both physical health and mood. […] If you or someone you know is experiencing symptoms of depression or struggling with the emotional challenges associated with short bowel syndrome, its crucial to seek professional help. A healthcare provider can offer guidance on managing both the physical and emotional aspects of the condition, improving overall quality of life.
  • #2 SciELO Brazil – Short bowel syndrome: treatment options Short bowel syndrome: treatment options
    https://www.scielo.br/j/jcol/a/bQSzfX9kHHDvFXvWWQxwJmJ/
    Patients with preservation of the colon can retain up to 1000 extra calories/day by bacterial fermentation. […] In recent decades, a new multidisciplinary approach to the treatment of these patients, HPN, was developed. […] HPN is indicated in situations where patients require prolonged PN, but without requiring hospitalization. […] The success of this adaptation depends on both the length and the portion of resected bowel, and will determine whether the patient will require a permanent or non-permanent total parenteral nutrition (TPN), a fact with great impact on quality of life (QoL) and prognosis. […] In cases where the treatment is not effective, one must opt for a surgical approach, including a intestinal transplantation. […] The last years have witnessed the development of new drug therapies, for instance, teduglutide and somatotropin, which promote intestinal rehabilitation, improve the function of the remaining bowel, and allow a significant reduction in PN needs.
  • #2 Targeted therapy of short-bowel syndrome with teduglutide: the new kid | CEG
    https://www.dovepress.com/targeted-therapy-of-short-bowel-syndrome-with-teduglutide-the-new-kid–peer-reviewed-fulltext-article-CEG
    The FDA recommends teduglutide at a dose of 0.05 mg/kg/day, to be administered once a day subcutaneously in the arms, thighs, or abdomen and by rotating the injection sites. […] With the recent approval of teduglutide, the medical management of SBS-IF has transformed from being supportive care to a more targeted therapy.
  • #2 Managing the Adult Patient With Short Bowel Syndrome – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/october-2017/managing-the-adult-patient-with-short-bowel-syndrome/
    An overarching goal when treating a patient with SBS who requires parenteral support is to reduce or, whenever possible, eliminate its use. […] Surgeries that recruit additional bowel into continuity, relieve obstruction, repair a fistula, and eliminate diseased bowel may improve residual bowel absorption or function. […] Management of the patient with SBS requires patience, persistence, and attention to detail. Risks to these patients are significant, often resulting in major detriments to quality of life and increased consumption of health care resources. A coordinated approach including dietary and fluid modifications, symptom-based conventional medications, selective use of intestinotrophic agents and surgery, and comorbid disease management, ideally by a multidisciplinary team, is important for the successful management of SBS.
  • #3 Short bowel syndrome – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/short-bowel-syndrome/symptoms-causes/syc-20355091
    Short bowel syndrome treatment typically involves special diets and nutritional supplements. It may involve receiving nutrition through a vein, called parenteral nutrition, to prevent malnutrition. […] Causes of short bowel syndrome include having parts of your small intestine removed during surgery, or being born with some of the small intestine missing or damaged. Conditions that may require surgical removal of portions of the small intestine include Crohn’s disease, cancer, injuries and blood clots.
  • #3 Short Bowel Syndrome: What It Is, Who Gets It, and More
    https://www.webmd.com/ibd-crohns-disease/crohns-disease/short-bowel-syndrome
    You may also get prescription diarrhea medicine and antacids. […] Treatment for short bowel syndrome can take years. Here’s a look at what you might expect. […] During the first three to four weeks of short bowel syndrome, you may get: […] Parenteral nutrition, where you receive the nutrients you need through an IV […] Enteral nutrition, where you receive liquid food through a tube implanted in your digestive tract […] Small amounts of food and drink that gradually increase as you’re able to take them in. […] It may take your intestine several years or more to get used to its short length and get back up to full power. During this phase, you might get: […] Less IV nutrition as your intestinal function improves […] More enteral nutrition as your intestine gets better able to absorb it […] More real food and drink. […] At this point, your intestines have healed and improved as much as they are going to. You may need to take up permanent lifestyle changes to make sure you can get all the nutrients you need to stay healthy.
  • #3 What Is Short Bowel Syndrome? | SBS
    https://www.shortbowelsyndrome.com/what-is-sbs
    PS is provided intravenously (IV), delivering fluids and/or nutrition directly into a vein. Parenteral support ranges from fluid electrolytes to a complete mix of nutrients. PS can be a lifesaving intervention for some people with SBS, but over the long term it is expensive, affects quality of life, and is associated with serious complications. […] TPN is a type of PS that provides a mixture of proteins, carbohydrates, fats, vitamins, and minerals and is customized to your specific nutrition needs. The liquid nutrients are delivered directly to your bloodstream through a large vein in your chest or arm. It is often used in the first few months following a surgery. […] Tube feeding, also known as enteral nutrition, or EN, delivers nutrients through a feeding tube directly into your stomach or small bowel for those with a partially functioning gastrointestinal (GI) tract. The feeding tubes are passed through the nose, mouth, or skin on your abdomen.
  • #3 Diagnosis and Treatment of Pediatric Short Bowel Syndrome and Intestinal Failure | NewYork-Presbyterian
    https://www.nyp.org/pediatrics/digestive-diseases/short-bowel-syndrome-and-intestinal-failure/diagnosis-and-treatment
    Enteral nutrition includes formula or blenderized foods that are delivered to the stomach or small intestine through a feeding tube (i.e., gastrostomy tube or gastrojejunostomy tube) […] Many children receiving enteral nutrition are also encouraged to eat small amounts of breast milk, formula, or food by mouth. This supports normal development of chewing, sucking, and swallowing. Feeding and occupational therapists support children as they learn to eat by mouth. […] Oral nutrition is individualized for your child to encourage foods that are easily digested and absorbed and discourage foods that worsen diarrhea. Our ultimate goal is for your child to be able to eat and absorb oral nutrients on their own. […] Your child’s pediatric surgeon will participate in your child’s team visits and will consider possible restorative surgeries that reshape the intestine to make it more functional. New York-Presbyterian Morgan Stanley Children’s Hospital is one of a few hospitals in the country to offer the serial transverse enteroplasty procedure (STEP), in which the small intestine is surgically reshaped to increase surface area and lengthen the amount of time it takes for food to move through it, increasing absorption of nutrients.
  • #3 Nutrition Guidelines for People With Short Bowel Syndrome | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/patient-education/nutrition-guidelines-people-short-bowel-syndrome
    Your body may not absorb nutrients, liquids, vitamins, and minerals as well as it did before your surgery. […] You can reduce these symptoms by following the guidelines in this resource. […] Follow these guidelines while your bowel recovers. […] Eat small, frequent meals to put less stress on your shortened bowel. […] Chew foods well to help break down food. […] Drink large amounts of liquids with meals. […] Your meals should be high in proteins. […] Include enough liquids in your diet. […] If you’re lactose intolerant, follow a low-lactose diet. […] Limit eating foods that are high in oxalates, such as spinach and rhubarb. […] If you’re having a lot of diarrhea, your doctor or clinical dietitian-nutritionist may recommend you drink an oral rehydration solution. […] A high-calorie liquid nutritional supplement may be helpful. […] Always ask your doctor or clinical dietitian-nutritionist before taking a supplement.
  • #3 Short Bowel Syndrome – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/malabsorption-syndromes/short-bowel-syndrome
    Cholestyramine 2 to 4 g taken with meals reduces diarrhea associated with bile acid malabsorption due to ileal resection. […] Monthly IM injections of vitamin B12 should be given to patients with a documented deficiency. […] Most patients should take supplemental vitamins, calcium, and magnesium. […] Gastric acid hypersecretion can develop, which can deactivate pancreatic enzymes; thus, most patients are given proton pump inhibitors. […] Small-bowel transplantation is advocated for patients who are not candidates for long-term TPN and in whom adaptation does not occur. […] Patients 1 year of age who require parenteral support may benefit from teduglutide or apraglutide (glucagon-like peptide-2 [GLP-2] analogs). […] Antidiarrheals, cholestyramine, proton pump inhibitors, and vitamin supplements are needed.
  • #3 Short bowel syndrome – Wikipedia
    https://en.wikipedia.org/wiki/Short_bowel_syndrome
    Treatment may include a specific diet, medications, or surgery. […] The diet may include slightly salty and slightly sweet liquids, vitamin and mineral supplements, small frequent meals, and the avoidance of high fat food. […] Occasionally, nutrients need to be given through an intravenous line, known as parenteral nutrition. […] Medications used may include antibiotics, antacids, loperamide, teduglutide, and growth hormone. […] The success rate of Teduglutide, defined as at least a 30% reduction in Parenteral nutrition, exceeded 50% of treated patients. […] Different types of surgery, including an intestinal transplant, may help some people. […] In 2004, the USFDA approved a therapy that reduces the frequency and volume of total parenteral nutrition (TPN), comprising: NutreStore (oral solution of glutamine) and Zorbtive (growth hormone, of recombinant DNA origin, for injection) together with a specialized oral diet.
  • #3 NICE recommends treatment for people with short bowel syndrome | NICE
    https://www.nice.org.uk/news/articles/nice-recommends-treatment-for-people-with-short-bowel-syndrome
    Clinical evidence showed teduglutide can help give people with short bowel syndrome greater normality by reducing the number of days per week people would require parenteral support. […] This treatment is a game-changer because it will reduce the burden on people with short bowel syndrome, their families and their carers. […] The recommended daily dose of teduglutide is 0.05 mg per kg body weight. […] Teduglutide is injected under the skin (subcutaneously) once daily.
  • #3 Short Bowel Syndrome | Doctor
    https://patient.info/doctor/short-bowel-syndrome
    A recombinant analog of glucagon-like peptide-2 (teduglutide) has been shown to result in a significant reduction in the requirement of intravenous fluids/parenteral nutrition. The National Institute for Health and Care Excellence (NICE) has recommended teduglutide as an option for treating SBS in people aged over 1 year, where it is provided under a commercial agreement. […] The treatment of SBS has to be individualised according to the clinical status of individual patients, and the decision on whether to resort to surgery and what operation to perform, depends upon many factors. […] For patients with SBS, surgery can play an important role in preventing, mitigating, and, in some cases, reversing intestinal failure. There are several surgical options for management, including construction of intestinal valves or reversed intestinal segments, interposition of segments of colon, or intestinal lengthening procedures.
  • #3 Surgical Treatment of Short Bowel Syndrome—The Past, the Present and the Future, a Descriptive Review of the Literature
    https://www.mdpi.com/2227-9067/9/7/1024
    A subcutaneously administered glucagon-like peptide-2 (GLP-2) analogue (teduglutide) has been found to increase intestinal absorption and reduce the need for parenteral support. […] The technical basis of intestinal transplantation (IT) was determined experimentally by Lillhei in 1959 and Starzl in 1960 using dogs. […] Indications for short bowel transplantation (SBT) are numerous; however, the grade of evidence is very low for any individual etiology. […] The most promising solution lies with tissue engineered small intestines (TESI).
  • #3 Short Bowel Syndrome Treatments | Bladder & Bowel Community
    https://www.bladderandbowel.org/bowel/bowel-treatments/short-bowel-syndrome-treatments/
    Surgery may be considered as a last resort if conservative and medicinal methods have failed to have any significant impact on the patients quality of life. […] The STEP procedure stands for Serial Transverse Enteroplasty and is a procedure where surgeons make incisions to change the shape of the bowel into a zigzag, which will increase the length and travel time of food along the small bowel therefore aiming to improve symptoms and nutrition levels. […] A small bowel transplant may be the very last resort, especially if you are reliant on TPN and have experienced liver failure as a result.
  • #3 Short bowel syndrome: how can gene and cell therapy help? | EuroGCT
    https://www.eurogct.org/short-bowel-syndrome-how-can-gene-and-cell-therapy-help
    For example, Nikhil Thapars laboratory at UCL has looked at ways to use stem cells to rebuild parts of the intestinal nervous system, which could treat individuals suffering from an enteric neuropathy (failure of the gut nervous system, sometimes also called Intestinal pseudoobstruction). Treatments that rebuild the intestines nervous system would greatly help prevent surgeries that lead to SBS. […] Researchers are also using stem cells and patient tissue to grow small intestine organoids (meaning organ-resembling). […] In cases where surgeries to remove the small intestine are unavoidable, stem cell transplants may be able to help repair the intestine after surgery and regrow some of the cells and tissue that has been lost. Alternatively, researchers part of the international collaborative INTENS project are examining how stem cells might be used to grow new segments of intestine on biological scaffolds that can be transplanted.
  • #3 Azthena logo with the word Azthena
    https://www.news-medical.net/news/20210217/Researchers-develop-a-better-solution-to-treat-short-bowel-syndrome.aspx
    Short Bowel Syndrome (SBS) is a medical disorder caused by a lack of a fully functional small intestine. Unfortunately, there is no cure for SBS, and current treatment options have low survival rates and can cause serious side-effects especially for children. That is why researchers with the EU-funded INTENS project are committed to developing a better solution. […] Today, treating SBS requires long-term parenteral nutrition (nutrition provided through the vein) or an organ transplant. While the former does not offer a definitive cure, the latter is associated with a shortage of organs. As a result, both treatment approaches are of a limited effect. […] To support this finding, De Coppi and his team transplanted the colon scaffolds in vivo, demonstrating that they can survive to form short-term functional structures. These findings provide proof-of-concept data for engineering patient-specific jejunal grafts for children with intestinal failure, ultimately restoring their nutritional autonomy, adds De Coppi.
  • #3 What Is SBS-IF? – Review Tables, Infographics, and Overviews
    https://www.gattexhcp.com/short-bowel-syndrome/
    Management of SBS is complex and requires an individualized approach. Important treatment goals for patients with SBS include maintaining adequate nutrition and hydration requirements, reducing or eliminating the need for parenteral support (PS) and increasing oral and/or enteral feeding, promoting intestinal adaptation, and minimizing disease- and parenteral support-related complications. […] While there is no cure for SBS, a multidisciplinary team can help manage it. Experts can include physicians, surgeons, nurses, dietitians, and/or social workers who may contribute to the success of achieving patients’ treatment goals. […] Patients with SBS often require parenteral support (PS). PS dependency can vary in nutritional components, frequency, and administration times. PS is lifesaving for patients with SBS but does not increase intestinal absorption. Patients often require PS to make up for reduced absorption. PS is supplementary nutrition and does not increase intestinal absorption, which will continue to be an issue for patients with SBS. […] GATTEX (teduglutide) for injection is indicated for the treatment of adults and pediatric patients 1 year of age and older with short bowel syndrome (SBS) who are dependent on parenteral support.
  • #3 GATTEX® (teduglutide) for Short Bowel Syndrome (SBS)
    https://www.gattex.com/
    If a blockage is found, your healthcare provider may temporarily stop GATTEX. […] Your healthcare provider will check you for too much fluid in your body. Too much fluid in your body may lead to heart failure, especially if you have heart problems. […] GATTEX may cause serious side effects, including: Making abnormal cells grow faster. […] GATTEX is given 1 time each day at the same time. […] If you miss a dose, take it as soon as you remember that day. Take your next dose the next day at the same time you take it every day. […] Do not stop taking GATTEX without consulting your healthcare provider.
  • #3 Mental Health & Short Bowel – Short Bowel Foundation
    https://shortbowelfoundation.org/mental-health-short-bowel-syndrome/
    It is crucial for individuals dealing with short bowel syndrome to adopt a comprehensive healthcare approach that integrates both medical and psychological support. Mental health professionals can assist individuals in managing anxiety and offer strategies to cope with stress associated with the condition. […] Its important for individuals with short bowel syndrome to have a comprehensive healthcare approach that includes both physical and mental health support. Mental health professionals can help individuals cope with the emotional aspects of living with a chronic condition.
  • #3 Exploring the Horizon: Emerging Treatments in Short Bowel Syndrome | Eclipse Regenesis
    https://www.eclipseregenesis.com/2024/03/28/exploring-the-horizon-emerging-treatments-in-short-bowel-syndrome/
    Short Bowel Syndrome (SBS) stands as a significant challenge in the realm of gastrointestinal disorders, affecting a wide range of individuals, from infants to adults. […] The traditional management of SBS, while effective to a degree, leaves much to be desired in terms of a long-term solution. […] The evolving landscape of Short Bowel Syndrome treatment is an area of intense research and innovation. […] Emerging Treatments in Short Bowel Syndrome _ Eclipse Regenesis Blog IMG3 […] The field of Short Bowel Syndrome treatment is witnessing exciting advancements, as researchers and medical professionals work tirelessly to develop more effective and less invasive solutions. […] One of the most promising areas of SBS treatment is regenerative medicine. […] Pharmacological research is also playing a key role in developing new treatments for SBS. […] Surgical techniques continue to evolve in treating SBS. […] The future of SBS treatment lies in personalized medicine and targeted therapies. […] The commitment of the medical community to research and development is paving the way for more effective and patient-centric solutions.
  • #4 Short Bowel Syndrome – IFFGD
    https://iffgd.org/gi-disorders/other-disorders/short-bowel-syndrome-2/
    Immediately following surgical resection of the small bowel, the bowel begins to compensate on its own for the loss of absorptive surface area. […] Enteral nutrition (delivery of liquid food to the stomach or small intestine through a feeding tube) may be needed during this phase. If a more significant length of small bowel is removed, then parenteral nutrition (delivery of fluids, electrolytes, and liquid nutrients into the bloodstream through a tube placed in a vein) is required. […] The maintenance phase is the last change where the absorptive capacity of the remaining bowel will be maximized. Some patients will still have dependence on parenteral or enteral nutrition. Others will meet their nutritional needs with oral meals, nutrition supplements, and vitamins and minerals, with or without supplements.
  • #4 Short Bowel Syndrome – IFFGD
    https://iffgd.org/gi-disorders/other-disorders/short-bowel-syndrome-2/
    The result of the adaptive period and the remaining small bowels ability to compensate determines the type of short bowel syndrome a person has. This can be either Intestinal Insufficiency or Intestinal Failure. Intestinal Insufficiency is when a patient has a reduced length of small bowel remaining but does NOT require IV nutrition or fluids. Those that do require such supportive measures are termed as having Intestinal Failure. […] Short bowel syndrome can occur in a person of any age. Risk factors for SBS include defects existing at birth and diseases of the small intestine that require extensive or recurrent surgery such as Crohns disease or gastrointestinal cancers. In addition, SBS can be caused by loss of function due to injury or disease in a normal length small intestine. Other explanations include emergency situations related to injury or trauma, perforated bowel, or blocked or restricted blood flow to the bowel.